home / stock / itrm / itrm quote
Last: | $1.57 |
---|---|
Change Percent: | 1.94% |
Open: | $1.52 |
Close: | $1.57 |
High: | $1.57 |
Low: | $1.5 |
Volume: | 50,845 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.57 | $1.52 | $1.57 | $1.57 | $1.5 | 50,845 | 04-25-2024 |
$1.55 | $1.6 | $1.55 | $1.6 | $1.5 | 35,939 | 04-24-2024 |
$1.58 | $1.57 | $1.58 | $1.6 | $1.55 | 36,278 | 04-23-2024 |
$1.58 | $1.46 | $1.58 | $1.6 | $1.46 | 197,643 | 04-22-2024 |
$1.43 | $1.42 | $1.43 | $1.51 | $1.42 | 60,950 | 04-19-2024 |
$1.43 | $1.44 | $1.43 | $1.47 | $1.43 | 56,746 | 04-18-2024 |
$1.46 | $1.48 | $1.46 | $1.496 | $1.42 | 76,340 | 04-17-2024 |
$1.45 | $1.55 | $1.45 | $1.55 | $1.45 | 169,564 | 04-16-2024 |
$1.57 | $1.58 | $1.57 | $1.63 | $1.5 | 98,833 | 04-15-2024 |
$1.58 | $1.62 | $1.58 | $1.6471 | $1.58 | 82,989 | 04-12-2024 |
$1.64 | $1.63 | $1.64 | $1.71 | $1.6001 | 45,789 | 04-11-2024 |
$1.64 | $1.65 | $1.64 | $1.74 | $1.61 | 136,157 | 04-10-2024 |
$1.67 | $1.71 | $1.67 | $1.7571 | $1.65 | 120,680 | 04-09-2024 |
$1.7 | $1.82 | $1.7 | $1.82 | $1.65 | 187,849 | 04-08-2024 |
$1.76 | $1.85 | $1.76 | $1.85 | $1.72 | 231,922 | 04-05-2024 |
$1.87 | $1.59 | $1.87 | $1.93 | $1.5899 | 753,646 | 04-04-2024 |
$1.55 | $1.58 | $1.55 | $1.6043 | $1.53 | 88,135 | 04-03-2024 |
$1.6 | $1.64 | $1.6 | $1.65 | $1.55 | 131,182 | 04-02-2024 |
$1.64 | $1.58 | $1.64 | $1.66 | $1.55 | 160,722 | 04-01-2024 |
$1.54 | $1.62 | $1.54 | $1.67 | $1.49 | 228,461 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Iterum Therapeutics plc Company Name:
ITRM Stock Symbol:
NASDAQ Market:
Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...
- -Resubmission of NDA On Track for Early Q2 24— - -Cash Runway into 2025, including through Potential FDA Approval in Early Q4 24-- --Company to host conference call today at 8:30amET-- DUBLIN, Ireland and CHICAGO, March 28, 2024 (GLOBE NEWSWIRE) -- Iterum ...